Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB)

CUSIP: 45782T105

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
27,969,231
Total 13F shares
274,538
Share change
+236,172
Total reported value
$1,620,000
Price per share
$5.90
Number of holders
9
Value change
+$1,390,869
Number of buys
8
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 45782T105?
CUSIP 45782T105 identifies INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of INMB - Inmune Bio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
DEUTSCHE BANK AG\
13F
Company
0.12%
33,333
$324,000 30 Jun 2019
13F
BlackRock Finance, Inc.
13F
Company
0.01%
3,048
$29,000 30 Jun 2019
13F
TRUE Private Wealth Advisors
13F
Company
0%
1,000
$9,000 30 Jun 2019
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
802
$8,000 30 Jun 2019
13F
UBS Group AG
13F
Company
0%
237
$2,000 30 Jun 2019
13F
Advisor Group, Inc.
13F
Company
0%
200
$2,000 30 Jun 2019
13F
LADENBURG THALMANN FINANCIAL SERVICES INC.
13F
Company
0%
100
$1,000 30 Jun 2019
13F

Institutional Holders of Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) as of Q3 2019

As of 30 Sep 2019, Inmune Bio, Inc. - Common Stock, par value $0.001 per share (INMB) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 274,538 shares. The largest 9 holders included Financial Advocates Investment Management, DEUTSCHE BANK AG\, BlackRock Inc., BANK OF AMERICA CORP /DE/, Covington Capital Management, VICTORY CAPITAL MANAGEMENT INC, UBS Group AG, Tower Research Capital LLC (TRC), and Advisor Group, Inc.. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q2 2019 Across Filers

Q2 2019 holders
7
Q3 2019 holders
9
Holder diff
2
Investor Q2 2019 Shares Q3 2019 Shares Share Diff Share Chg % Q2 2019 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .